UQ Professor appointed to PHARMAC in New Zealand
The Pharmaceutical Management Agency (PHARMAC) in the New Zealand has appointed The University of Queensland’s Professor Jennifer Martin as a new member to the Pharmacology and Therapeutics Advisory Committee (PTAC).
Professor Martin, Head of the Princess Alexandra Clinical School at the UQ School of Medicine, said it is exciting to be able to contribute to international pharmaceutical policy decisions.
“These decisions actually have effects on pricing of, and access to medications in many other countries looking to publicly fund pharmaceuticals,” Professor Martin said.
“I am especially delighted and honoured to be contributing to the New Zealand Ministry of Health as there is such a necessary focus on value for money here.
“Spending on pharmaceuticals, whilst improving health outcomes, also diverts resources from other areas of health which can likewise benefit the health of the nation.
“So we need to ensure we know the amount the drug or device will cost and the likely benefit to the population, and how this compares to other proposed health interventions that require Government funding,” she said.PHARMAC Medical Director Dr John Wyeth said the new appointment will add to the high calibre of PTAC’s membership.”PTAC’s advice is one of the foundation stones of PHARMAC’s decisions and it is essential we have the best possible people on the committee,” he said.
Professor Martin is a Clinical Pharmacologist who has played a leading role in medicine assessment in Australia, both at a state and Australia-wide level.
She attended Wellington East Girls College before graduating from the University of Otago School of Medicine, and then a Rhodes Scholar at Oxford University in the UK.
About the UQ Medical School’s Doctor of Medicine
Program: Doctor of Medicine (MD) commencing 2015
Location: Brisbane or Ipswich, Queensland
Semester intake: January
Duration: 4 years
Application deadline: UQ Medical School applications are assessed on a rolling admissions (first come, first served) basis. OzTREKK recommends that applicants apply early to increase their chances of timely assessment.
- Completed degree (Bachelor, Master, PhD)
- GPA equivalent to 5.0 on UQ’s 7.0 scale
- MCAT score (minimum of 8/8/8 or 8/8/M/8) or GAMSAT score (minimum of 50 in each section)
- Compulsory consultative meeting with the UQ School of Medicine
About the UQ Pharmacy School’s Bachelor of Pharmacy
Program: Bachelor of Pharmacy (BPharm)
Location: Brisbane, Queensland
Semester intake: February
Duration: 4 years
Application deadline: November 15, 2014
Applicants to UQ’s BPharm program are required to have completed their high school diploma. Applicants should have completed Grade 12 English, Chemistry and Math to meet program prerequisites.
If you have commenced or completed a university degree or any post-secondary studies, your most recent studies will be assessed in terms of your grades. If you have not completed the necessary prerequisite subjects in your post-secondary studies, your high school transcripts will then be assessed for prerequisite subjects.
Many international students with prior study (especially those with a science background) are able to enter directly into Year 2 of the Bachelor of Pharmacy. If credit is awarded, students can undertake an additional course in their first and second semester of enrollment and complete the program in three years.
Should you receive an offer to study in the UQ Pharmacy School program, you will be eligible to apply for credit and accelerate into Year 2 of your studies. Please note this is only after you have received an offer.